GLP-1 or its receptor agonist improved glucose uptake in heart by increasing GLUT4 translocation, and led to cardiac performance preservation in dilated cardiomyopathy or myocardial infarction induced failing heart [16], [43], [44]. The gene discussed is SLC2A4; the disease is dilated cardiomyopathy.